Literature DB >> 26968235

The role of octamer binding transcription factors in glioblastoma multiforme.

A K Rooj1, A Bronisz1, J Godlewski1.   

Abstract

A group of transcription factors (TF) that are master developmental regulators of the establishment and maintenance of pluripotency during embryogenesis play additional roles to control tissue homeostasis and regeneration in adults. Among these TFs, members of the octamer-binding transcription factor (OCT) gene family are well documented as major regulators controlling the self-renewal and pluripotency of stem cells isolated from different adult organs including the brain. In the last few years a large number of studies show the aberrant expression and dysfunction of OCT in different types of cancers including glioblastoma multiforme (GBM). GBM is the most common malignant primary brain tumor, and contains a subpopulation of undifferentiated stem cells (GSCs), with self-renewal and tumorigenic potential that contribute to tumor initiation, invasion, recurrence, and therapeutic resistance. In this review, we have summarized the current knowledge about OCT family in GBM and their crucial role in the initiation, maintenance and drug resistance properties of GSCs. This article is part of a Special Issue entitled: The Oct Transcription Factor Family, edited by Dr. Dean Tantin.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cancer stem cell; Glioblastoma multiforme; Octamer-binding transcription factor; Tumor microenvironment

Mesh:

Substances:

Year:  2016        PMID: 26968235      PMCID: PMC4880501          DOI: 10.1016/j.bbagrm.2016.03.003

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  105 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

2.  Hedgehog signaling in the subventricular zone is required for both the maintenance of stem cells and the migration of newborn neurons.

Authors:  Francesca Balordi; Gord Fishell
Journal:  J Neurosci       Date:  2007-05-30       Impact factor: 6.167

3.  Oct1 loss of function induces a coordinate metabolic shift that opposes tumorigenicity.

Authors:  Arvind Shakya; Robert Cooksey; James E Cox; Victoria Wang; Donald A McClain; Dean Tantin
Journal:  Nat Cell Biol       Date:  2009-02-15       Impact factor: 28.824

4.  MicroRNA-451 regulates LKB1/AMPK signaling and allows adaptation to metabolic stress in glioma cells.

Authors:  Jakub Godlewski; Michal O Nowicki; Agnieszka Bronisz; Gerard Nuovo; Jeff Palatini; Michael De Lay; James Van Brocklyn; Michael C Ostrowski; E Antonio Chiocca; Sean E Lawler
Journal:  Mol Cell       Date:  2010-03-12       Impact factor: 17.970

Review 5.  STAT3 as a central mediator of neoplastic cellular transformation.

Authors:  David A Frank
Journal:  Cancer Lett       Date:  2006-11-28       Impact factor: 8.679

6.  The B-cell-specific Oct-2 protein contains POU box- and homeo box-type domains.

Authors:  R G Clerc; L M Corcoran; J H LeBowitz; D Baltimore; P A Sharp
Journal:  Genes Dev       Date:  1988-12       Impact factor: 11.361

7.  Oct4 is expressed in human gliomas and promotes colony formation in glioma cells.

Authors:  Zhanhui Du; Deyong Jia; Shangming Liu; Fuwu Wang; Gang Li; Yanmin Zhang; Xinmin Cao; Eng-Ang Ling; Aijun Hao
Journal:  Glia       Date:  2009-05       Impact factor: 7.452

8.  OCT4 is epigenetically regulated by DNA hypomethylation of promoter and exon in primary gliomas.

Authors:  Jinlong Shi; Wei Shi; Lanchun Ni; Xide Xu; Xing Su; Liang Xia; Feng Xu; Jian Chen; Jianhong Zhu
Journal:  Oncol Rep       Date:  2013-05-13       Impact factor: 3.906

9.  cDNA cloning of human N-Oct3, a nervous-system specific POU domain transcription factor binding to the octamer DNA motif.

Authors:  E Schreiber; A Tobler; U Malipiero; W Schaffner; A Fontana
Journal:  Nucleic Acids Res       Date:  1993-01-25       Impact factor: 16.971

10.  Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer.

Authors:  Zhou Du; Teng Fei; Roel G W Verhaak; Zhen Su; Yong Zhang; Myles Brown; Yiwen Chen; X Shirley Liu
Journal:  Nat Struct Mol Biol       Date:  2013-06-02       Impact factor: 15.369

View more
  6 in total

1.  Collective invasion of glioma cells through OCT1 signalling and interaction with reactive astrocytes after surgery.

Authors:  Yangjin Kim; Donggu Lee; Sean Lawler
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2020-07-27       Impact factor: 6.237

Review 2.  Glucose transport: meeting the metabolic demands of cancer, and applications in glioblastoma treatment.

Authors:  Collin M Labak; Paul Y Wang; Rishab Arora; Maheedhara R Guda; Swapna Asuthkar; Andrew J Tsung; Kiran K Velpula
Journal:  Am J Cancer Res       Date:  2016-08-01       Impact factor: 6.166

Review 3.  Glioblastoma: new therapeutic strategies to address cellular and genomic complexity.

Authors:  Xue Cai; Michael E Sughrue
Journal:  Oncotarget       Date:  2017-12-20

4.  Polyphenols Extracted from Artemisia annua L. Exhibit Anti-Cancer Effects on Radio-Resistant MDA-MB-231 Human Breast Cancer Cells by Suppressing Stem Cell Phenotype, β-Catenin, and MMP-9.

Authors:  Young Shin Ko; Eun Joo Jung; Se-Il Go; Bae Kwon Jeong; Gon Sup Kim; Jin-Myung Jung; Soon Chan Hong; Choong Won Kim; Hye Jung Kim; Won Sup Lee
Journal:  Molecules       Date:  2020-04-21       Impact factor: 4.411

5.  Hypoxic Roadmap of Glioblastoma-Learning about Directions and Distances in the Brain Tumor Environment.

Authors:  Agnieszka Bronisz; Elżbieta Salińska; E Antonio Chiocca; Jakub Godlewski
Journal:  Cancers (Basel)       Date:  2020-05-13       Impact factor: 6.639

6.  Master Regulators Connectivity Map: A Transcription Factors-Centered Approach to Drug Repositioning.

Authors:  Marco A De Bastiani; Bianca Pfaffenseller; Fabio Klamt
Journal:  Front Pharmacol       Date:  2018-07-02       Impact factor: 5.810

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.